| Charles M Bernstein, MD | |
|
1 Medical Village Dr, St. Elizabeth Healthcare, Edgewood, KY 41017 | |
| (859) 301-2423 | |
| (859) 301-2066 |
| Full Name | Charles M Bernstein |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 1 Medical Village Dr, Edgewood, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053302018 | NPI | - | NPPES |
| 2282177 | Medicaid | OH | |
| 64046386 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 35069035 (Ohio) | Secondary |
| 207R00000X | Internal Medicine | 39184 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles M Bernstein, MD Po Box 635283, Cincinnati, OH 45263-5283 Ph: (859) 344-5555 | Charles M Bernstein, MD 1 Medical Village Dr, St. Elizabeth Healthcare, Edgewood, KY 41017 Ph: (859) 301-2423 |
News Archive
Wanting to replace the medical equipment for taking X-rays, the Mexican Society of Radiology (CMR) created a system of digital x-ray imaging, which replaces the traditional plaque by a solid detector, which delivers results in five seconds. Analog equipment take six minutes to develop the traditional film.
PHC, Inc., d/b/a Pioneer Behavioral Health, a leading provider of inpatient and outpatient behavioral health services, today announced that it has signed an agreement to acquire MeadowWood Behavioral Health, located in New Castle, Delaware, for $21.5 million, subject to customary purchase price adjustments. The transaction is expected to close late in the second quarter of 2011.
Researchers from Aalto University have found the mechanism of action for cancer-cell-killing peptides. This breakthrough is expected to lead to better medication, in particular better treatments for leukemia, skin cancer, and infections caused by multi-resistant bacteria.
Mild cognitive impairment (MCI) is a slight but noticeable and measurable decline in cognitive abilities, such as remembering names or a list of items. While changes may not be severe enough to disrupt daily life, a clinical diagnosis of MCI indicates an increased risk of eventually developing Alzheimer's disease or another type of dementia.
Regenerative medicine company Mesoblast Limited today announced that it has received regulatory clearance from the Singapore Health Sciences Authority (HSA) to commence the first Phase 2 trial of its proprietary allogeneic (off-the-shelf) adult stem cell therapy for patients with proliferation of leaky blood vessels in the eyes – neovascular Age-related Macular Degeneration.
› Verified 8 days ago
Alice Hall, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-8074 Fax: 859-301-4945 | |
Colleen M Darnell, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-4000 Fax: 859-301-4001 | |
Vidya Rajaram Devarajan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-757-4446 Fax: 859-344-1999 | |
Dr. Minsig Choi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-4000 Fax: 859-301-4001 | |
Robert J Wagner, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-8074 Fax: 859-301-4945 | |
Ryan Daniel Weprin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Village Dr, Edgewood, KY 41017 Phone: 859-301-8074 Fax: 859-301-4945 |